POLE GENE MUTATION

Clinical trials for POLE GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new POLE GENE MUTATION trials appear

Sign up with your email to follow new studies for POLE GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for hard-to-treat cancers? drug targets tumors with unstable genes

Disease control Ongoing

This study tests the drug pembrolizumab in 21 adults with advanced solid tumors that have specific gene mutations (BRCA1, BRCA2, POLE, or POLD1). The goal is to see if the drug can shrink or control the cancer. Pembrolizumab is a type of immunotherapy that helps the immune system…

Matched conditions: POLE GENE MUTATION

Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control

Last updated May 12, 2026 13:39 UTC

POLE GENE MUTATION

Get alerted when new POLE GENE MUTATION trials appear

New hope for hard-to-treat cancers? drug targets tumors with unstable genes